BIOMARIN PHARMACEUTICAL INC Other Payments to Acquire Businesses
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Payments to Acquire Businesses of $4.69 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:OtherPaymentsToAcquireBusinesses · last filed 2015-03-02
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for the quarter ending 2014-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for the quarter ending 2013-12-31 was $3.06M, a 30.51% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for the quarter ending 2013-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for fiscal 2014 was $4.69M, a 53.25% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for fiscal 2013 was $3.06M, a 30.51% decline from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for fiscal 2012 was $4.41M, a 132.58% increase from fiscal 2011.
- BIOMARIN PHARMACEUTICAL INC other payments to acquire businesses for fiscal 2011 was $1.89M, a 88.06% decline from fiscal 2010.
| Period end | Other Payments to Acquire Businesses 1 month | Other Payments to Acquire Businesses 3 month | Other Payments to Acquire Businesses 6 month | Other Payments to Acquire Businesses 9 month | Other Payments to Acquire Businesses 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $4.69M 10-K · filed 2015-03-02 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $4.69M 10-Q · filed 2014-10-28 | |||
| 2014-06-30 | $4.69M 10-Q · filed 2014-07-31 | ||||
| 2013-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $3.06M derived: sum of 2 quarters · filed 2015-03-02 | $3.06M 10-K · filed 2015-03-02 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $0.00 10-Q · filed 2014-10-28 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-31 | ||||
| 2012-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $4.41M 10-K · filed 2015-03-02 | |||
| 2012-10-31 | $6.00M 10-K · filed 2013-02-26 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2012-10-29 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $1.89M derived: sum of 2 quarters · filed 2014-02-26 | $1.89M 10-K · filed 2014-02-26 | ||
| 2011-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $1.89M 10-Q · filed 2012-10-29 | |||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-01 | ||||
| 2010-12-31 | $9.63M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $9.63M derived: sum of 2 quarters · filed 2013-02-26 | $15.86M 10-K · filed 2013-02-26 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $6.23M 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | $6.23M 10-Q · filed 2011-08-01 | ||||
| 2009-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $1.00M derived: sum of 2 quarters · filed 2012-02-22 | $1.00M 10-K · filed 2012-02-22 | ||
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $0.00 10-Q · filed 2010-10-29 | |||
| 2009-06-30 | $0.00 10-Q · filed 2010-08-04 | ||||
| 2008-12-31 | $0.00 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |